Evaluation of the safety and efficacy of continuous use of skincare formulations - Evaluation of the safety and efficacy of continuous use of skincare formulations

Beauty & Health Research Inc.0 sites45 target enrollmentMarch 25, 2020

ConditionsHealthy

Overview

Phase: 未知
Intervention: Not specified
Conditions: Healthy
Sponsor: Beauty & Health Research Inc.
Enrollment: 45
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

No summary available.

Registry

who.int

Start Date

March 25, 2020

End Date

April 27, 2020

Last Updated

2 years ago

Study Type

Interventional

Sex

Female

Investigators

Sponsor

Beauty & Health Research Inc.

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•1\)Subjects who have a facial injury 2\)Those who used a medicinal product that can potentially affect the study within 3 months of the start of the study or who will probably use a drug that can potentially affect the results during the study period 3\)Subjects who underwent a cosmetic procedure such as collagen or hyaluronic acid injection, botox injection, chemical peeling, laser therapy, or phototherapy within 6 months of the start of the study or who will probably undergo one of the above\-mentioned cosmetic procedures during the study period 4\)Those currently receiving hormone replacement therapy or who will probably receive hormone replacement therapy during the study period 5\)Those who will probably experience substantial exposure to sunlight during the study 6\)Those who have previously developed serious skin problems arising from the use of cosmetic products or other similar products 7\)Those who have previously developed dermatitis due to adhesive tape or other similar products 8\)Subjects whose face is affected by atopic dermatitis or another skin disease 9\)Those who suffer from severe hay fever 10\)Those who habitually consume excess amounts of alcohol 11\)Those who are unable to discontinue drugs that can potentially affect the study results 12\)Those who have a history of severe liver disease, kidney disease, myocardial infarction, or other similar serious conditions and who will probably start to receive a new treatment at a medical institution during the study period 13\)Those who suffer from severe anemia 14\)Those who are pregnant or will potentially become pregnant during the study or who are breast\-feeding 15\)Those who will have participated in another clinical study between 3 months before screening and the end of this study or will probably participate in another clinical study during this study period 16\)Subjects whose enrollment in the study is considered inappropriate by the principal investigator